HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Dietary Supplements Deals Consumer

Omega Protein, Dr. Axe, No Cow: Health And Wellness Industry News

This article was originally published in The Rose Sheet

  • News

Executive Summary

Omega Protein stockholders vote Dec. 19 on proposed acquisition by Cooke; Endexx acquires Holistic Earth Remedies to improve timing for CBD product commercialization; Dr. Axe brands protein; and more health and wellness industry news.

You may also be interested in...



Health, Beauty And Wellness News: Medline Remedy Contamination, GNC Proxy

Omega Protein, Herbalife, MET-Rx: Health And Wellness Industry News

Omega Protein has new home at Canadian aquaculture firm; Herbalife on target with buy-back tender volume, price; and MET-Rx scores Bellinger for promotions.

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.

Table

View full table

Topics

Related Companies

Tags:
Dietary Supplements Deals Consumer
Latest Headlines

MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In

Cosmetic And Personal Care Trademark Review: 16 April

Health And Wellness Weekly Trademarks Review: 16 April

Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States

See All
UsernamePublicRestriction

Register

RS121341

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By